Microenvironment‐Regulating Drug Delivery Nanoparticles for Treating and Preventing Typical Biofilm‐Induced Oral Diseases
Advanced Materials · 2025
DOI: 10.1002/adma.202304982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Leyi Xiao und 5 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, Schoo…. Hauptthemen laut MEDLINE: Biofilms, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The oral cavity comprises an environment full of microorganisms. Dysregulation of this microbial‐cellular microenvironment will lead to a series of oral diseases, such as implant‐associated infection caused by Staphylococcus aureus ( S. aureus ) biofilms and periodontitis initiated by Streptococcus oralis ( S. oralis ). In this study, a liposome‐encapsulated indocyanine green (ICG) and rapamycin drug‐delivery nanoparticle (ICG‐rapamycin) is designed to treat and prevent two typical biofilm‐induced oral diseases by regulating the microbial‐cellular microenvironment. ICG‐rapamycin elevates the reactive oxygen species (ROS) and temperature levels to facilitate photodynamic and photothermal mechanisms under near‐infrared (NIR) laser irradiation for anti‐bacteria. In addition, it prevents biofilm formation by promoting bacterial motility with increasing the ATP levels. The nanoparticles modulate the microbial‐cellular interaction to reduce cellular inflammation and enhance bacterial clearance, which includes promoting the M2 polarization of macrophages, upregulating the anti‐inflammatory factor TGF‐β, and enhancing the bacterial phagocytosis of macrophages. Based on these findings, ICG‐rapamycin is applied to implant‐infected and periodontitis animal models to confirm the effects in vivo. This study demonstrates that ICG‐rapamycin can treat and prevent biofilm‐induced oral diseases by regulating the microbial‐cellular microenvironment, thus providing a promising strategy for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, P. R. Ch…
- Medical Research Institute School of Medicine, Wuhan University, Wuhan, 430071, P. R. China.
- TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, P. R. China.
ORCID-Profile: Yufeng Zhang
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Xiao, L., Feng, M., Chen, C., Xiao, Q., Cui, Y., & Zhang, Y. (2025). Microenvironment‐Regulating Drug Delivery Nanoparticles for Treating and Preventing Typical Biofilm‐Induced Oral Diseases. Advanced Materials. https://doi.org/10.1002/adma.202304982
Vancouver
Xiao L, Feng M, Chen C, Xiao Q, Cui Y, Zhang Y. Microenvironment‐Regulating Drug Delivery Nanoparticles for Treating and Preventing Typical Biofilm‐Induced Oral Diseases. Advanced Materials. 2025. doi:10.1002/adma.202304982
BibTeX
@article{Xiao2025,
author = {Xiao, Leyi and Feng, Mengge and Chen, Chen and Xiao, Qi and Cui, Yu and Zhang, Yufeng},
title = {Microenvironment‐Regulating Drug Delivery Nanoparticles for Treating and Preventing Typical Biofilm‐Induced Oral Diseases},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202304982}
}
EUVIMED